Table 3
Frequencies of Types of Effects Observed in Home Telemonitoring Studies, n (%)
| Pulmonary Conditions | Diabetes | Cardiac Diseases | Hypertension | Total | |
| Number of studies | 18 | 17 | 16 | 14 | 65 |
| Data quality | 12 (67) | 10 (59) | 5 (31) | 9 (64) | 36 (55) |
| Patient condition | 13 (72) | 16 (94) | 12 (75) | 10 (71) | 51 (78) |
| Patient attitudes and behaviors | 16 (89) | 15 (88) | 13 (81) | 11 (79) | 55 (85) |
| Clinical effectiveness/ structural effects | 9 (50) | 8 (47) | 12 (75) | 3 (21) | 32 (49) |
| Economic viability | 6 (33) | 3 (18) | 4 (25) | 4 (29) | 17 (26) |
